YOLFTbeta
49

LivsMed

491000 · KQ · Healthcare / Medical Devices

33,800.00KRW-400.00 (-1.17%)

Price History

Full chart

Market Stats

Previous Close34,200.00
Open34,200.00
Day Range33,650.00 – 37,900.00
52-Week Range27,100.00 – 95,900.00
Volume695.07K
Market Cap907.66B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg35,754.00
200-Day Avg54,974.48

About

Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. The company offers ArtiSential, a multi-joint articulating surgical instrument that is used for laparoscopic surgeries, as well as training kits. It exports to the Unites States, Germany, etc. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jung Joo Lee
  • Employees313
  • Headquarters304,D-dong, Seongnam-si, South Korea, 13516, Korea
  • Websitehttps://livsmed.com

Leadership

  • Mr. Jung Joo LeeCEO & Director · b. 1975
  • Mr. Se-yoon OhCFO & Director · b. 1967
  • Mr. Ji-hwan JeonChief Strategy Officer & Director · b. 1973

Financials

Income Statement

Currency: KRW2024-12-312025-12-31
Total Revenue27.12B51.19B
Growth (%)-+88.75%
Cost of Revenue12.57B21.66B
Gross Profit14.55B29.53B
Gross Margin53.64%57.69%
Operating Expense41.05B52.18B
Operating Income-26.50B-22.64B
Operating Margin-97.73%-44.23%
EBITDA-15.32B-19.32B
EBITDA Margin-56.50%-37.73%
Net Income-25.58B-22.87B
Net Income Margin-94.33%-44.68%
R&D10.70B14.16B
R&D as % of Total Revenue39.44%27.66%
Interest Expense8.61B822.33M
Interest Expense % of Total Revenue31.76%1.61%

Balance Sheet

Currency: KRW2024-12-312025-12-31
Total Assets53.26B201.93B
Total Liabilities13.65B21.06B
Total Equity39.60B180.87B
Cash16.82B11.40B

Cash Flow

Currency: KRW2024-12-312025-12-31
Operating Cash Flow-27.66B-34.74B
Capital Expenditure4.46B7.72B
Free Cash Flow-32.12B-42.46B
FCF to OCF116.10%122.23%

Earnings

Report DateDec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---
EPS Actual-230.04-236.13-441.11
Surprise---
Timing---

Key Statistics & Ratios

Market Cap907.66B
Enterprise Value694.48B
Trailing P/E0.00
Forward P/E0.00
Price / Sales17.18
Price / Book4.55
Revenue (TTM)52.82B
Gross Profit (TTM)26.47B
EBITDA-27.37B
Profit Margin-50.25%
Operating Margin-97.46%
Return on Equity-24.04%
Return on Assets-14.81%
Shares Outstanding25.00M
Shares Float13.55M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%